ALGENTECH

Our mission is to solve current technological bottlenecks in the field of genome engineering and bring novel approaches to the market... Our focus is on the development of nuclease-free methods and design of booster systems to improve efficiency of nuclease-based genome editing technologies with unparalleled efficiency of gene targeting in eukaryotic cells via homologous recombination... Algentech specialises in the development of cutting edge technologies for gene editing and synthetic biology tools applications for multi-sectorial applications. The company was incorporated in 2009, is a member of the Genopole BioCluster and performs its R&D activities at the INRA center in Versailles.

Also known as: Algentech SAS